{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T03:29:10Z","timestamp":1795058950497,"version":"4.10.2"},"reference-count":57,"publisher":"American Chemical Society (ACS)","issue":"3","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_ccby_termsofuse.html"}],"funder":[{"DOI":"10.13039\/na","name":"Vyera Pharmaceuticals","doi-asserted-by":"publisher","award":["NA"],"award-info":[{"award-number":["NA"]}],"id":[{"id":"10.13039\/na","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>A safer treatment for toxoplasmosis would be achieved by improving the selectivity and potency of dihydrofolate reductase (DHFR) inhibitors, such as pyrimethamine (1), for Toxoplasma gondii DHFR (TgDHFR) relative to human DHFR (hDHFR). We previously reported on the identification of meta-biphenyl analog 2, designed by in silico modeling of key differences in the binding pocket between TgDHFR and hDHFR. Compound 2 improves TgDHFR selectivity 6.6-fold and potency 16-fold relative to 1. Here, we report on the optimization and structure\u2013activity relationships of this arylpiperazine series leading to the discovery of 5-(4-(3-(2-methoxypyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine 3. Compound 3 has a TgDHFR IC50 of 1.57 \u00b1 0.11 nM and a hDHFR to TgDHFR selectivity ratio of 196, making it 89-fold more potent and 16-fold more selective than 1. Compound 3 was highly effective in control of acute infection by highly virulent strains of T. gondii in the murine model, and it possesses the best combination of selectivity, potency, and prerequisite drug-like properties to advance into IND-enabling, preclinical development.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.8b01754","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T14:42:18Z","timestamp":1547044938000},"page":"1562-1576","source":"Crossref","is-referenced-by-count":63,"title":["Discovery of Selective\n                    <i>Toxoplasma gondii<\/i>\n                    Dihydrofolate Reductase Inhibitors for\nthe Treatment of Toxoplasmosis"],"prefix":"10.1021","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8797-7882","authenticated-orcid":true,"given":"Allen T.","family":"Hopper","sequence":"first","affiliation":[{"name":"Vyera Pharmaceuticals, LLC , 600 Third Avenue, 10th Floor , , ,","place":["New York, New York, United States, 10016"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Brockman","sequence":"additional","affiliation":[{"name":"Vyera Pharmaceuticals, LLC , 600 Third Avenue, 10th Floor , , ,","place":["New York, New York, United States, 10016"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Wise","sequence":"additional","affiliation":[{"name":"Evotec (UK) LTD. , Alderley Park , ,","place":["Cheshire, U.K., SK104TG"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gould","sequence":"additional","affiliation":[{"name":"Evotec (UK) LTD. , Alderley Park , ,","place":["Cheshire, U.K., SK104TG"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Barks","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine , , 660 S. Euclid Avenue , , ,","place":["St. Louis, Missouri, United States, 63130"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Radke","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine , , 660 S. Euclid Avenue , , ,","place":["St. Louis, Missouri, United States, 63130"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7110-0285","authenticated-orcid":true,"given":"L. David","family":"Sibley","sequence":"additional","affiliation":[{"name":"Washington University School of Medicine , , 660 S. Euclid Avenue , , ,","place":["St. Louis, Missouri, United States, 63130"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmao","family":"Zou","sequence":"additional","affiliation":[{"name":"WuXi AppTec (Tianjin) Co., Ltd. , 168 NanHai Road, 10th Avenue, TEDA , ,","place":["Tianjin, P. R. China, 300457"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Thomas","sequence":"additional","affiliation":[{"name":"Vyera Pharmaceuticals, LLC , 600 Third Avenue, 10th Floor , , ,","place":["New York, New York, United States, 10016"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2019,1,9]]},"reference":[{"issue":"2","key":"2026090314021938400_cit1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1128\/CMR.11.2.267","article-title":"Structures of Toxoplasma gondii tachyzoites,\nbradyzoites, and sporozoites and biology and development of tissue\ncysts","volume":"11","author":"Dubey","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"issue":"12\u201313","key":"2026090314021938400_cit2","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to\nhumans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int. J. Parasitol."},{"issue":"7","key":"2026090314021938400_cit3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005648","article-title":"Congenital\ntoxoplasmosis in Austria: Prenatal screening\nfor prevention is cost-saving","volume":"11","author":"Prusa","year":"2017","journal-title":"PLoS Neglected\nTrop. Dis."},{"issue":"1","key":"2026090314021938400_cit4","first-page":"1","article-title":"Latent toxoplasmosis and human","volume":"7","author":"Dalimi","year":"2012","journal-title":"Iran J. Parasitol."},{"key":"2026090314021938400_cit5","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/B978-1-4557-4801-3.00280-0","article-title":"Toxoplasma gondii","volume-title":"Mandell, Douglas, and\nBennett\u2019s Principles and Practice of Infectious Diseases","author":"Montoya","year":"2015","edition":"8"},{"key":"2026090314021938400_cit6","first-page":"125","article-title":"Toxoplasmosis","volume-title":"Handbook of Clinical Neurology","author":"Halonen","year":"2013"},{"issue":"6","key":"2026090314021938400_cit7","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00005792-199411000-00004","article-title":"Extracerebral toxoplasmosis in patients infected with\nHIV. A French national survey","volume":"73","author":"Rabaud","year":"1994","journal-title":"Medicine (Philadelphia,\nPA, U. S.)"},{"key":"2026090314021938400_cit8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0952-7915(99)00051-5","article-title":"The role of\nIL-18 in innate immunity","volume":"12","author":"Akira","year":"2000","journal-title":"Curr. Opin. Immunol."},{"issue":"14","key":"2026090314021938400_cit9","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1097\/QAD.0000000000001174","article-title":"Toxoplasma\nmyocarditis: a rare but serious complication\nin an HIV-infected late presenter","volume":"30","author":"Cuervo","year":"2016","journal-title":"AIDS"},{"issue":"9425","key":"2026090314021938400_cit10","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"issue":"Suppl.\n4","key":"2026090314021938400_cit11","doi-asserted-by":"publisher","first-page":"S247","DOI":"10.1086\/430785","article-title":"Drug resistance\nhampers our capacity to roll back malaria","volume":"41","author":"Olliaro","year":"2005","journal-title":"Clin.\nInfect. Dis."},{"key":"2026090314021938400_cit12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1017\/CBO9780511527005.015","article-title":"Antitoxoplasma\nChemotherapy","volume-title":"Toxoplasmosis: A Comprehensive\nClinical Guide","author":"McCabe","year":"2001"},{"issue":"4","key":"2026090314021938400_cit13","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s40268-017-0206-8","article-title":"Adverse event profile of pyrimethamine-based\ntherapy in toxoplasmosis: A systematic review","volume":"17","author":"Ben-Harari","year":"2017","journal-title":"Drugs R&D"},{"issue":"3","key":"2026090314021938400_cit14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/bcpt.12206","article-title":"An outbreak of pyrimethamine toxicity in patients with\nischaemic heart disease in pakistan","volume":"115","author":"Khan Assir","year":"2014","journal-title":"Basic Clin.\nPharmacol. Toxicol."},{"key":"2026090314021938400_cit15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2307\/4588050","article-title":"Tests of 2,4-diaminopyrimidines on toxoplasmosis","volume":"67","author":"Eyles","year":"1952","journal-title":"Public Health Rep."},{"issue":"4","key":"2026090314021938400_cit16","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ajo.2013.12.022","article-title":"Trimethoprim-sulfamethoxazole versus placebo to reduce\nthe risk of recurrences of Toxoplasma gondii retinochoroiditis: Randomized\ncontrolled clinical trial","volume":"157","author":"Felix","year":"2014","journal-title":"Am. J. Ophthalmol."},{"issue":"5","key":"2026090314021938400_cit17","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S0161-6420(03)00083-6","article-title":"Antibiotics for\ntoxoplasmic retinochoroiditis: An evidence-based systematic review","volume":"110","author":"Stanford","year":"2003","journal-title":"Ophthalmology"},{"key":"2026090314021938400_cit18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.cimid.2016.09.002","article-title":"Molecular assessment of the transplacental transmission\nof Toxoplasma gondii, Neospora caninum, Brucella canis and Ehrlichia\ncanis in dogs","volume":"49","author":"Taques","year":"2016","journal-title":"Comparative immunology, microbiology\nand infectious diseases"},{"issue":"6","key":"2026090314021938400_cit19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2165\/00002018-200730060-00003","article-title":"Safety\nand toxicity\nof sulfadoxine\/pyrimethamine implications for malaria prevention in\npregnancy using intermittent preventive treatment","volume":"30","author":"Peters","year":"2007","journal-title":"Drug Saf."},{"issue":"2","key":"2026090314021938400_cit20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/BF00917741","article-title":"Allergic manifestations\nof human\nimmunodeficiency virus (HIV) infection","volume":"11","author":"Carr","year":"1991","journal-title":"J. Clin.\nImmunol."},{"issue":"4","key":"2026090314021938400_cit21","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/ACI.0b013e32825ea68a","article-title":"Drug hypersensitivity in HIV","volume":"7","author":"Phillips","year":"2007","journal-title":"Curr. Opin Allergy Clin Immunol"},{"issue":"3","key":"2026090314021938400_cit22","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.iac.2004.03.011","article-title":"Sulfonamide hypersensitivity","volume":"24","author":"Slatore","year":"2004","journal-title":"Immunol. Allergy Clin. North Am."},{"issue":"6","key":"2026090314021938400_cit23","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/0306-3623(94)90149-X","article-title":"GABAergic and dopaminergic\nsystems may be involved\nin seizures induced by pyrimethamine in mice","volume":"25","author":"Amabeoku","year":"1994","journal-title":"Gen. Pharmacol."},{"issue":"21","key":"2026090314021938400_cit24","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1021\/jm8009124","article-title":"Structure-based\napproach to the development of potent and selective inhibitors of\ndihydrofolate reductase from Cryptosporidium","volume":"51","author":"Bolstad","year":"2008","journal-title":"J. Med. Chem."},{"issue":"13","key":"2026090314021938400_cit25","doi-asserted-by":"publisher","first-page":"4420","DOI":"10.1021\/jm0581718","article-title":"Design, synthesis,\nand antifolate activity of new analogues of piritrexim and other diaminopyrimidine\ndihydrofolate reductase inhibitors with \u03c9-carboxyalkoxy or \u03c9-carboxy-1-alkynyl\nsubstitution in the side chain","volume":"48","author":"Chan","year":"2005","journal-title":"J. Med. Chem."},{"issue":"6","key":"2026090314021938400_cit26","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1128\/AAC.40.6.1371","article-title":"6,7-Disubstituted 2,4-diaminopteridines:\nNovel inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate\nreductase","volume":"40","author":"Jackson","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"2026090314021938400_cit27","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1021\/jm061027h","article-title":"Highly\nefficient ligands for dihydrofolate reductase from Cryptosporidium\nhominis and Toxoplasma gondii inspired by structural analysis","volume":"50","author":"Pelphrey","year":"2007","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026090314021938400_cit28","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1128\/AAC.39.1.79","article-title":"Structure-activity\nand structure-selectivity\nstudies on diaminoquinazolines and other inhibitors of Pneumocystis\ncarinii and Toxoplasma gondii dihydrofolate reductase","volume":"39","author":"Rosowsky","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"issue":"41","key":"2026090314021938400_cit29","doi-asserted-by":"publisher","first-page":"7305","DOI":"10.1021\/bi400576t","article-title":"First three-dimensional\nstructure of Toxoplasma gondii thymidylate synthase-dihydrofolate\nreductase: Insights for catalysis, interdomain interactions, and substrate\nchanneling","volume":"52","author":"Sharma","year":"2013","journal-title":"Biochemistry"},{"issue":"12","key":"2026090314021938400_cit30","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1021\/acsmedchemlett.6b00328","article-title":"Discovery of potent and selective\nleads against Toxoplasma\ngondii dihydrofolate reductase via structure-based design","volume":"7","author":"Welsch","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"2026090314021938400_cit31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1172\/JCI112837","article-title":"Potent in vitro and\nin vivo antitoxoplasma activity of the lipid-soluble\nantifolate trimetrexate","volume":"79","author":"Allegra","year":"1987","journal-title":"J. Clin. Invest."},{"key":"2026090314021938400_cit32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.ejmech.2017.04.070","article-title":"Host dihydrofolate\nreductase (DHFR)-directed cycloguanil analogues endowed with activity\nagainst influenza virus and respiratory syncytial virus","volume":"135","author":"Tonelli","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"2026090314021938400_cit33","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1590\/S0037-86822012000400014","article-title":"In vitro action\nof antiparasitic drugs, especially artesunate, against Toxoplasma\ngondii","volume":"45","author":"Gomes","year":"2012","journal-title":"Rev. Soc. Bras Med. Trop"},{"issue":"21","key":"2026090314021938400_cit34","doi-asserted-by":"publisher","first-page":"7451","DOI":"10.1021\/jo101478c","article-title":"A versatile and\npractical microwave-assisted synthesis\nof sterically hindered N-arylpiperazines","volume":"75","author":"Gao","year":"2010","journal-title":"J.\nOrg. Chem."},{"issue":"30","key":"2026090314021938400_cit35","doi-asserted-by":"publisher","first-page":"4541","DOI":"10.1016\/j.tetlet.2015.06.003","article-title":"An efficient scale up process for\nsynthesis of N-arylpiperazines","volume":"56","author":"Ravilla","year":"2015","journal-title":"Tetrahedron\nLett."},{"issue":"41","key":"2026090314021938400_cit36","doi-asserted-by":"publisher","first-page":"7318","DOI":"10.1021\/bi400852h","article-title":"Elucidating\nfeatures\nthat drive the design of selective antifolates using crystal structures\nof human dihydrofolate reductase","volume":"52","author":"Lamb","year":"2013","journal-title":"Biochemistry"},{"key":"2026090314021938400_cit37","unstructured":"UniProtKB, U. UniProtKB-P00374\n(DYR_HUMAN) [database entry for human DHFR] (accessed November 2,\n2017)."},{"key":"2026090314021938400_cit38","doi-asserted-by":"publisher","first-page":"5844","DOI":"10.1073\/pnas.1203190109","article-title":"Globally diverse Toxoplasma gondii isolates comprise six major clades originating from\na small number of distinct ancestral lineages","volume":"109","author":"Su","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"2026090314021938400_cit39","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1086\/342663","article-title":"Genotype\nof 86 Toxoplasma gondii isolates\nassociated with human congenital toxoplasmosis and correlation with\nclinical findings","volume":"186","author":"Ajzenberg","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"8","key":"2026090314021938400_cit40","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1086\/597477","article-title":"Genotype of 88 Toxoplasma gondii isolates\nassociated with toxoplasmosis in immunocompromised patients and correlation\nwith clinical findings","volume":"199","author":"Ajzenberg","year":"2009","journal-title":"J. Infect. Dis."},{"key":"2026090314021938400_cit41","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","article-title":"Toxoplasma gondii comprises three\nclonal lineages: correlation of parasite genotype with human disease","volume":"172","author":"Howe","year":"1995","journal-title":"J. Infect. Dis."},{"key":"2026090314021938400_cit42","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2307\/3281034","article-title":"Antigenic differences between endozoites\nand cystozoites\nof Toxoplasma gondii","volume":"69","author":"Lunde","year":"1983","journal-title":"J. Parasitol."},{"issue":"6","key":"2026090314021938400_cit43","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","article-title":"Toxoplasma gondii\ncomprises three clonal lineages:\ncorrelation of parasite genotype with human disease","volume":"172","author":"Howe","year":"1995","journal-title":"J. Infect. Dis."},{"key":"2026090314021938400_cit44","doi-asserted-by":"publisher","first-page":"5881","DOI":"10.1128\/JCM.43.12.5881-5887.2005","article-title":"Genotyping\nof Toxoplasma gondii strains from immunocompromised\npatients reveals high prevalence of type I strains","volume":"43","author":"Khan","year":"2005","journal-title":"J. Clin. Micro."},{"key":"2026090314021938400_cit45","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.1073\/pnas.172117099","article-title":"Identification\nof quantitative trait loci controlling acute virulence in Toxoplasma gondii","volume":"99","author":"Su","year":"2002","journal-title":"Proc. Natl. Acad.\nSci. U. S. A."},{"key":"2026090314021938400_cit46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2460\/ajvr.1980.41.03.427","article-title":"Mouse pathogenicity\nof Toxoplasma gondii isolated from a goat","volume":"41","author":"Dubey","year":"1980","journal-title":"Am. J. Vet. Res."},{"key":"2026090314021938400_cit47","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1128\/JCM.40.11.4037-4044.2002","article-title":"Severe\nacquired toxoplasmosis in immunocompetent adult patients in French\nGuiana","volume":"40","author":"Carme","year":"2002","journal-title":"J. Clin. Microbiol."},{"issue":"7","key":"2026090314021938400_cit48","doi-asserted-by":"publisher","first-page":"E221","DOI":"10.1111\/j.1469-0691.2011.03648.x","article-title":"Acute toxoplasmoses\nin immunocompetent\npatients hospitalized in an intensive care unit in French Guiana","volume":"18","author":"Demar","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"2026090314021938400_cit49","doi-asserted-by":"publisher","first-page":"10147","DOI":"10.1038\/ncomms10147","article-title":"Local admixture\nof amplified and diversified secreted pathogenesis determinants shapes\nmosaic Toxoplasma gondii genomes","volume":"7","author":"Lorenzi","year":"2016","journal-title":"Nat. Commun."},{"issue":"6","key":"2026090314021938400_cit50","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.1074\/jbc.273.6.3461","article-title":"A biochemical and\ngenetic model for parasite resistance\nto antifolates. Toxoplasma gondii provides insights into pyrimethamine\nand cycloguanil resistance in Plasmodium falciparum","volume":"273","author":"Reynolds","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2026090314021938400_cit51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002992","article-title":"The polymorphic\npseudokinase ROP5 controls virulence\nin Toxoplasma gondii by regulating the active kinase\nROP18","volume":"8","author":"Behnke","year":"2012","journal-title":"PLoS Pathog."},{"issue":"3","key":"2026090314021938400_cit52","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jac\/36.3.503","article-title":"A new murine model\nof severe acute toxoplasma encephalitis","volume":"36","author":"Arribas","year":"1995","journal-title":"J.\nAntimicrob. Chemother."},{"issue":"3","key":"2026090314021938400_cit53","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.exppara.2012.12.011","article-title":"Toxoplasma\ngondii: The effect of\nfluconazole combined with sulfadiazine and pyrimethamine against acute\ntoxoplasmosis in murine model","volume":"133","author":"Martins-Duarte","year":"2013","journal-title":"Exp. Parasitol."},{"issue":"8","key":"2026090314021938400_cit54","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1128\/AAC.34.8.1467","article-title":"In vivo assessment\nof antimicrobial agents against toxoplasma gondii by quantification\nof parasites in the blood, lungs, and brain of infected mice","volume":"34","author":"Piketty","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6","key":"2026090314021938400_cit55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039961","article-title":"High-throughput\nscreening and sensitized bacteria identify an M. tuberculosis dihydrofolate\nreductase inhibitor with whole cell activity","volume":"7","author":"Kumar","year":"2012","journal-title":"PLoS One"},{"key":"2026090314021938400_cit56","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1021\/jm4001314","article-title":"Optimizing\nsmall molecule inhibitors of calcium-dependent protein kinase 1 to\nprevent infection by Toxoplasma gondii","volume":"56","author":"Lourido","year":"2013","journal-title":"J. Med. Chem."},{"issue":"1","key":"2026090314021938400_cit57","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1128\/IAI.05543-11","article-title":"A patatin-like protein protects Toxoplasma gondii from\ndegradation in a nitric oxide-dependent manner","volume":"80","author":"Tobin","year":"2012","journal-title":"Infect. Immun."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.8b01754","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/62\/3\/1562\/67315964\/acs.jmedchem.8b01754.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/62\/3\/1562\/67315964\/acs.jmedchem.8b01754.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:02:23Z","timestamp":1788458543000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/62\/3\/1562\/1537144\/Discovery-of-Selective-Toxoplasma-gondii"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,9]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,1,9]]},"published-print":{"date-parts":[[2019,2,14]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01754","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01754.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1021\/acs.jmedchem.8b01754.s002","asserted-by":"subject"}]},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,9]]}}}